Skip to main content
. Author manuscript; available in PMC: 2018 Jan 17.
Published in final edited form as: AIDS Behav. 2016 Aug;20(8):1621–1631. doi: 10.1007/s10461-016-1316-y

Table 2.

Sensitivity and specificity of the five screening tools for HIV-D, any HAND and symptomatic HAND

Cut-off point Sensitivity (%) Specificity (%) PPV (%) NPV (%)
IHDS (≤10)
Normal vs. HAND 40.95 86.00 86.00 40.95
Normal vs. Symptomatic 51.56 86.00 82.50 58.11
Normal vs. HIV-D 68.42 86.00 65.00 87.76
IHDS (≤11)
Normal vs. HAND 64.76 62.00 78.16 45.59
Normal vs. Symptomatic 68.75 62.00 69.84 60.78
Normal vs. HIV-D 73.68 62.00 42.42 86.11
MoCA (≤26)
Normal vs. HAND 89.32 22.45 70.77 50.00
Normal vs. Symptomatic 90.48 22.45 60.00 64.71
Normal vs. HIV-D 100.00 22.45 32.14 100.00
MMSE (≤24)
Normal vs. HAND 23.81 97.96 96.15 37.50
Normal vs. Symptomatic 24.62 97.96 94.12 49.48
Normal vs. HIV-D 26.32 97.96 83.33 77.42
SSQ (≥1)
Normal vs. HAND 77.64 32.00 69.37 35.56
Normal vs. Symptomatic 75.38 32.00 59.04 50.00
Normal vs. HIV-D 78.95 32.00 30.61 80.00
CAT-Rapid (≤10)
Normal vs. HAND 64.42 52.00 73.63 41.27
Normal vs. Symptomatic 78.12 52.00 67.57 65.00
Normal vs. HIV-D 94.44 52.00 41.46 96.30

IHDS International HIV-Dementia Scale, MoCA Montreal Cognitive Assessment, MMSE Mini-mental state examination, SSQ Simioni, Symptom Questionnaire, CAT-Rapid Cognitive Assessment Tool-Rapid, HAND HIV-associated neurocognitive disorder = Asymptomatic Neurocognitive Impairment or Mild Neurocognitive Disorder or HIV-Dementia, HIV-D HIV Dementia, PPV positive predictive value, NPV negative predictive value. Combined scores unavailable for 3 participants (N = 153)